Meeting
2018 Gastrointestinal Cancers Symposium
Current Status of mCRC in East Europe and Middle East.
Authors
Ozan Yazici
Ankara Numune Education and Research Hospital, Ankara, Turkey
Ozan Yazici , Gokhan Ucar , Vamvakopoulou Vasileia , Serdar Nazim Turhal , Birol Yildiz , Michalis Karamouzis , Sinan Yavuz , Nuri Karadurmus , Nurullah Zengin , Huseyin Abali , Ravit Geva
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 853)
DOI
10.1200/JCO.2018.36.4_suppl.853
Abstract #
853
Poster Bd #
P5
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
ISO-CC-005: A phase I/II study of Modufolin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer.
First Author: Helena Anna Taflin
Poster
2015 Gastrointestinal Cancers Symposium
Randomized phase II studies comparing pathological responses observed on colorectal cancer metastases resected after preoperative treatment combining bevacizumab or cetuximab with FOLFOX or FOLFIRI.
First Author: Marc Van Den Eynde
First Author: Axel Grothey
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Effectiveness of biologic agents among Hispanics in the US with metastatic colorectal cancer.
First Author: Riya Jayesh Patel